Search
for
Sort by
Research 331–360 of 1000+
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- LB1157 Befriending the bugs: An updated meta-analysis on the efficacy of probiotic intervention in reducing scorad scores in atopic dermatitis
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience
- Serum interleukin-37 and its gene polymorphism (rs3811047) in Egyptian patients with alopecia areata
- Does zinc have a role in alopecia areata? A clinic-biochemical study
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe alopecia areata
- An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- The Association Between Clinical and Biochemical Hyperandrogenism in Women With Female Pattern Hair Loss
- Frontal Fibrosing Alopecia: An Update on Pathogenesis, Diagnosis, and Treatment
- Spironolactone therapy for hidradenitis suppurativa
- Holistic Ayurvedic Management of Psoriasis with special reference to Eka Kustha
- Assessment of Serum Level of Brain-Derived Neurotrophic Factor (BDNF) In Pediatric Alopecia Areata: A Case - Control Study
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Adult female acne: Clinical characteristics and factors significantly associated with polycystic ovary syndrome
- Comparison of the therapeutic effects of the dietary and topical forms of Zizyphus jujuba extract on oral mucositis induced by 5-fluorouracil: A golden hamster model
- Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome
- Comparison of Trichoscopic Features of Alopecia Areata before and after Treatment with Intralesional Steroids
- Clinical and anamnestic features of alopecia areata in ukrainian men
- Molecular Morbidity Score–Can MicroRNAs Assess the Burden of Disease?
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- Correlations between dermatology life quality index and trichoscopic and clinical-anamnestic parameters in Ukrainian men with alopecia areata
- Evaluating the Predictors of Persistent Long COVID Symptoms and Their Severity in COVID-19 Survivors 1 Year After Infection
- Comparison of self-assessed and clinician-assessed hirsutism diagnosed according to the modified Ferriman-Gallwey scale among female outpatients in Brazil
- Clinical and demographic factors associated with nail involvement in adult alopecia areata patients at Al-Kadhmia teaching hospital, Baghdad, 2023
- Making sense of measures of clinical signs for atopic dermatitis